While analyst coverage of VTVT is relatively quiet, the two on board are extremely bullish. Both call the penny stock a “buy,” and the consensus 12-month target price is all the way up at $6.50 — …
More VTVT Stock Eyes Fresh High on Upbeat Diabetes Drug Data Videos